Luspatercept in Patients Affected With Rare Inherited Anemias

Clinical trial NCT07331818 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07331818
Sponsor: EuroBloodNet Association
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hereditary Red Blood Cell Disorder (Disorder)

Start date: 2026-01-15
Primary completion: 2028-09-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.